In enteric bacteria, L-glutamate serves important roles as the primary donor of amino groups in the biosynthesis of other nitrogenous compounds (13) and as the potassium counterion in osmotic homeostasis (6) . Enteric bacteria synthesize glutamate either by the pathway mediated by glutamine synthetase (GS) and glutamine, 2-oxoglutarate amidotransferase (GOGAT) or by the pathway mediated by only glutamate dehydrogenase (GDH) (for reviews, see references 21 and 28). In the absence of a functional GS-GOGAT pathway, the rate of glutamate biosynthesis by the GDH pathway alone may restrict growth under nitrogen-limited or hyperosmotic conditions (7, 18) . Although the mechanism regulating the expression of GS in enteric bacteria has been studied extensively, those regulating GOGAT and GDH remain poorly understood (21) .
In general, GDH activities in cells grown in minimal medium are tenfold higher than those in cells grown in amino acid-rich medium (3, 4) . Although the factors contributing to this tenfold difference are unknown, several studies suggest that supplements such as casamino acids, glutamate, or other amino acids to minimal medium may each repress GDH expression as much as threefold (21) . The activity of GDH in minimal medium-grown Klebsiella pneumoniae is reduced twofold in response to supplementation of the medium with L-lysine HCl to 0.01% (wt/vol) (550 M) (10) . This lysine-dependent repression of GDH acts at the transcriptional level (10) . The lysinedependent repression of GDH activity may contribute to the differential expression of GDH during growth in minimal and amino acid-rich media.
Another pattern of GDH expression that is inconsistently seen among enteric bacteria occurs during nitrogen-limited growth in minimal medium. In K. pneumoniae, nitrogen-limited growth results in tenfold or greater repression of the gdhA promoter, gdhAp, by the nitrogen assimilation control (NAC) protein (21) . NAC also weakly represses the K. pneumoniae gdhA promoter two-to threefold by a second mechanism that requires only the upstream NAC binding site centered at Ϫ89 and is independent of the ability of NAC dimers to tetramerize (8, 22) . This weaker NAC-mediated repression of gdhAp is abolished when the growth medium is supplemented with 550 M lysine or when gdhAp carries either the A(Ϫ96)T substitution or the ⌬Ϫ82 deletion that removes part of the NAC binding site centered at Ϫ87 (8, 22) . In addition, the lysinedependent regulation of gdhAp is essentially abolished when gdhAp carries either the A(Ϫ96)T substitution or the ⌬Ϫ82 deletion (8) . The similar effects that these modifications to gdhAp have on the weak NAC-mediated repression and the lysine-dependent repression suggest that these repression mechanisms act through a common mechanism to reduce gdhAp activity two-to threefold. Thus, it was proposed that exogenous lysine and NAC interfere with the ability of a putative transcriptional activator to stimulate transcription from gdhAp during growth in minimal medium. Although the mechanism by which exogenous lysine interferes with this stimulation was unclear, the data suggested that the weaker NACmediated repression of gdhAp results from the mutually exclusive binding of NAC and this putative lysine-sensitive transcriptional activator to overlapping binding sites in the upstream region of gdhAp (8, 22) . The identity of the putative lysine-sensitive transcriptional activator remained obscure until it was reported that either exogenous lysine or the disruption of the argP gene led to an osmosensitive phenotype in GOGAT-deficient Escherichia coli strains (18) . This phenotype results from the inability of these strains to up-regulate GDH expression and increase intracellular glutamate levels under hyperosmotic growth conditions. As ArgP, the product of the argP gene, is known to be a DNA-binding transcription factor (17) , it was speculated that ArgP stimulated the E. coli and K. pneumoniae gdhA promoters in a manner analogous to the lysine-sensitive activation of the E. coli argO promoter, argOp, by ArgP (17, 18) . In addition, purified E. coli ArgP was shown to bind the upstream region of the E. coli argO promoter and either prevent transcription in the presence of lysine or activate transcription in the presence of either L-arginine or its analog L-canavanine (11) .
NAC and ArgP are members of the LysR-type transcriptional regulator (LTTR) family of proteins, all of which display a significant level of amino acid sequence homology (24) . Studies of the LTTR-dependent regulation of target promoters suggest that many of these proteins use a common mechanism to activate their target promoters (20 and see reference 24 for a recent description). Basically, this emerging paradigm postulates that the LTTR interacts with two closely spaced, dissimilar binding sites that lie in the regions upstream of target promoters. The promoter-distal binding site, often referred to as the recognition binding site (RBS), contains the centrally located LTTR consensus binding motif (5Ј-T-N 11 -A-3Ј) and provides interactions that are required to anchor the LTTR to the upstream region of the target promoter. The LTTR binds to the RBS regardless of the presence of the effector, a lowmolecular-weight molecule that binds to and alters the conformation of the LTTR (20, 24) . The promoter-proximal binding site, referred to as the activation binding site (ABS), provides secondary interactions required for the LTTR-dependent activation of the target promoter. The LTTR binds to alternate sites within the ABS in response to effector-induced changes in the conformation of the LTTR. The effector-free and effectorbound conformations of the LTTR, bound to alternate sites in the ABS, have different abilities to productively interact with RNA polymerase and stimulate transcription from the target promoter (20, 24) .
In this study, these aspects of the LTTR paradigm were tested using the K. pneumoniae ArgP-gdhAp system.
MATERIALS AND METHODS
Bacterial strains, plasmids, fusions, growth conditions, and in vivo assays. All K. pneumoniae strains used in this study were derived from strain KC2653 (⌬bla-2 hutC515 str-6), an ampicillin-sensitive (Amp s ), streptomycin-resistant (Str r ) derivative of KC1043 (12) that was obtained from the laboratory of R. A. Bender. Plasmid pCB532 is a derivative of the lacZ fusion vector pRS415 (25) that carries ⌽(gdhApЈ-ЈlacZ), a transcriptional fusion of the region from Ϫ116 to ϩ75, relative to the gdhAp transcription start site, to the lacZ reporter gene (8) . Plasmid pCB725 is a derivative of vector pRJ800 (2) , which also carries the region from Ϫ116 to ϩ75 relative to the gdhAp transcription start site (10) .
All derivatives of KC2653 were grown at 30°C in LB medium or W4 minimal medium (12) supplemented with 0.4% (wt/vol) glucose as a carbon source and 0.2% ammonium sulfate plus 0.2% L-glutamine as combined nitrogen sources. Where it is indicated, minimal medium was supplemented with L-lysine HCl, L-arginine HCl, or L-canavanine sulfate to the specified concentrations. Media for plasmid and marker selection were supplemented with antibiotics, as follows: ampicillin (75 g of the monosodium salt/ml), streptomycin (100 g of the sulfate salt/ml), kanamycin (50 g of the sulfate salt/ml), and chloramphenicol (30 g/ml).
The assay for ␤-galactosidase was carried out by standard methods as described previously (12) using cultures that were grown to 50 Klett units (approximately 2 ϫ 10 8 CFU/ml). Specific activities are reported as nanomoles of product formed per minute per milligram of protein (U/mg) and represent the average of three or more assays, with a standard error of the mean (SEM) that is less than 10% of the average. DNA manipulation. In general, the methods outlined by Maniatis et al. (14) were used to manipulate the DNA. PCR was performed with either Taq DNA polymerase (Gibco-BRL and Invitrogen), as described previously (7), or rTth polymerase (Perkin-Elmer), as specified by the supplier. Custom oligodeoxynucleotide primers were supplied by Gibco-BRL and Invitrogen. Primers for amplifying the previously uncharacterized rbsA, rbsK, argP, and rpiA regions from the K. pneumoniae W70 chromosome were designed using the chromosomal sequence of K. pneumoniae MGH78578 (15), a clinical isolate closely related to K. pneumoniae W70. DNA sequences were determined by using the automated fluorescent dye termination method at the University of Michigan Core facility. DNA fragments carrying substitutions within gdhAp were amplified with mutagenic primers from pCB532 and pCB725, purified, digested with appropriate restriction enzymes, and cloned into pRS415 and pRJ800, respectively. The sequences of all PCR-generated DNA inserts cloned into pRS415 and pRJ800 were confirmed by DNA sequencing.
Construction of a landing pad plasmid for chromosomal insertions at the rbs locus. Plasmid pCB1578 is a so-called "landing pad" vector that facilitates the integration of cloned DNA fragments into the rbs locus on the K. pneumoniae W70 chromosome. This plasmid is a derivative of the pir-dependent alleleexchange vector pKAS46 (26) carrying DNA fragments that were obtained either by PCR or from plasmid pRS415 (Fig. 1A) . All derivatives of pKAS46 were replicated in the pir ϩ E. coli strain BW20767 (16) . The construction of pCB1578 involved several intermediate cloning steps employing standard methods. Essentially, 1.4-and 0.9-kb DNA fragments corresponding to the carboxyl terminally truncated rbsA gene (lacking the last 25 codons, ⌬rbsA75) and the amino terminally truncated rbsK gene (lacking the initiating methionine codon, ⌬rbsK3), respectively, were amplified from the K. pneumoniae W70 chromosome. These amplified DNA fragments were purified, digested with the appropriate restriction enzymes, and, after intermediate cloning steps, were ultimately cloned into pKAS46 with the same polarity as that found on the K. pneumoniae MGH78578 chromosome. The ⌬rbsA75 and ⌬rbsK3 sequences of pCB1578 provide regions of DNA homology to facilitate the recombination of the derivatives of this plasmid into the rbs locus on the K. pneumoniae W70 chromosome. In addition, a 40-bp BamHI-SacI DNA fragment carrying the multiple-cloning region (MCR) from pBC KS(ϩ) (Stratagene) and a 1. transcriptional terminators (T 1 /T 2 ) and the EcoRI restriction site from pRS415 were cloned between ⌬rbsA75 and ⌬rbsK3 such that transcription initiated upstream of ⌬rbsA75 is terminated before the MCR (Fig. 1A) . In effect, T 1 /T 2 and MCR carried by pCB1578 replace the rbsB and rbsC genes that lie between rbsA and rbsK on the K. pneumoniae chromosome. Thus, pCB1578 carries a deletion within the rbs operon that lacks the 3Ј end of rbsA, all of rbsB, all of rbsC, and the 5Јend of rbsK, hereafter referred to as ⌬rbs753. In addition, pCB1578 carries an insertion of T 1 /T 2 and the MCR, hereafter referred to as ⍀(T 1 /T 2 MCR), between ⌬rbsA75 and ⌬rbsK3.
Construction of chromosomal fusions at the rbs locus. All pRS415-based fusions used for in vivo studies were first cloned into the MCR of pCB1578 prior to recombination into the rbs locus on the KC2653 chromosome. Essentially, 3.4-kb DraI-EcoRI DNA fragments carrying either ⌽(gdhApЈ-ЈlacZ) from pCB532 or comparable pRS415-based plasmids were cloned into pCB1578, which had been digested with SacI, blunt-ended with T4 DNA polymerase, and digested with EcoRI. When the 3.4-kb fragment from pCB532 was cloned into pCB1578, this generated ⌬rbs753 ⍀(T 1 /T 2 MCR ⍀CB532), hereafter referred to as ⌬rbs753 ⍀CB532. Derivatives of pCB1578 carrying these fusions were introduced into strain KC2653 by electroporation, as described previously (22) Ϫ were then used for in vivo studies. When ⌽(gdhApЈ-ЈlacZ) carried by pCB532 was integrated onto the K. pneumoniae chromosome using this procedure, the wild-type rbs allele was replaced by ⌬rbs375 ⍀CB532.
Construction of K. pneumoniae argP28. The construction of the K. pneumoniae argP28 allele also utilized the pir-dependent allele-exchange vector pKAS64, with a strategy similar to that used for the integration of lacZ fusions into the rbs locus; however, for this construction, the cat gene, which confers resistance to chloramphenicol (Cam Essentially, a 1.9-kb DNA fragment carrying the divergently transcribed rpiA and argP genes was amplified from the K. pneumoniae W70 chromosome, purified, digested with the appropriate restriction enzymes, and, after an intermediate cloning step, was ultimately cloned into pKAS46. The DNA sequence of the cloned argP open reading frame differed from that reported for K. pneumoniae MGH78578 by a single base pair substitution that resulted in a synonymous proline codon change (in strain W70, 5Ј-CCA-Ј3; and in strain MGH78578, 5Ј-CCG-3Ј) at codon position 190 of argP. This single base pair substitution was also found in the cloned DNA sequences of two other argP open reading frames that were independently amplified from the K. pneumoniae W70 chromosome. A 1.4-kb fragment carrying the cat gene was purified from BspHI-digested pBC KS(ϩ), blunt ended, and ligated into the Eco47-III site within argP, generating the argP28⍀cat allele, hereafter referred to as argP28. Thus, the DNA fragment carrying the cat gene was inserted after nucleotide 28 of the argP open reading frame in the pKAS46-based pCB1590 plasmid.
Plasmid pCB1590 was introduced into derivatives of KC2653 by electroporation, followed by selection for . The growth rates of wild-type and argP28 derivatives of KC2653 were similar on all media tested and were not strongly influenced by supplements of either 550 M lysine, 10 mM arginine, or 500 M canavanine to the minimal medium. Thus, although wildtype E. coli is modestly sensitive to canavanine, wild-type Salmonella enterica serovar Typhimurium (5) and both the wild-type and the argP28 derivatives of K. pneumoniae KC2653 are relatively canavanine-resistant.
Extract preparation and electrophoretic mobility shift assay. The cells in cultures of K. pneumoniae that were grown to 50 Klett units in minimal medium with the indicated supplements were harvested by centrifugation at 4°C, washed, suspended at 100-fold concentration (about 10 mg of protein/ml) in ice-cold sonication buffer (10 mM imidazole [pH 7.8], 10 mM MgCl 2 , 10% [vol/vol] glycerol), and subjected to sonic disruption on ice. The cellular debris was pelleted by centrifugation at 10,000 ϫ g at 4°C, and the soluble fraction, hereafter referred to as the extract, was recovered and stored at Ϫ20°C. Where the relative amounts of gdhAp-binding activities in extracts were compared, the extracts were prepared on the same day, stored side by side until used, and verified to contain comparable amounts of protein.
For electrophoretic mobility shift experiments, pCB725 and other pRJ800-based derivatives were digested with EcoRI and HindIII, end labeled with [␣-32 P]dATP, using the Klenow fragment of DNA polymerase, precipitated with ethanol, and dissolved in distilled water. For these experiments, 4-l solutions containing 0.1 fmol (0.5 ng) of digested, end-labeled DNA, 1.5 g doublestranded poly(d[IC]) (Sigma Chemical Co., St. Louis, MO), 75 mM KCl, 5 mM Tris HCl (pH 7.0), 2.5 mM MgCl 2 , 1 mM dithio-DL-threitol (DTT), 0.5 mM CaCl 2 , 50 g acetylated bovine serum albumin (BSA), and where indicated, L-lysine HCl, L-arginine HCl, or L-canavanine sulfate at the specified concentrations were mixed with 1 l of either sonication buffer or extract. The resulting 5-l solutions were supplemented with 1 l of loading solution (15% [wt/vol] Ficoll, 0.25% bromophenol blue, 0.25% xylene cyanol), loaded onto 4% (wt/vol) polyacrylamide-TE (pH 8.4) gels (14) , and subjected to electrophoresis at 4°C. After electrophoresis, the gels were dried and subjected to autoradiography.
When the DNA targets carried regions of gdhAp that were less than 50 bp, they were amplified from pCB725 and cloned into pCB1307, a derivative of pRJ800, into which was cloned a 200-bp carrier DNA fragment. The pCB1307 control plasmid and its derivatives carrying the smaller amplified DNA fragments were end-labeled as described above, generating a control target composed of the 200-bp carrier fragment alone and the experimental composite targets composed of the 200-bp carrier fragment ligated to the smaller amplified fragments. These end-labeled DNA preparations were used as targets in mobility shift assays in which the presence of extracts or ArgP did not influence the mobility of the control DNA target (data not shown).
Construction of pCB1603 and the overexpression and purification of ArgPHis. A modified argP open reading frame carrying six CAC (histidine) codons at its 3Ј end was amplified from the K. pneumoniae W70 chromosome and cloned between the NdeI and EcoRI sites of the thermally inducible pJLA503 expression vector (23), yielding pCB1603. The DNA sequence of the argP open reading frame carried by pCB1603 was identical to that carried by pCB1590, except that it lacked the DNA fragment carrying the cat gene and carried the expected six histidine codons at the 3Ј of the open reading frame. The modified argP open reading frame of pCB1603 encodes ArgP-His, an affinity-tagged version of the ArgP polypeptide that carries an additional six histidine residues at its carboxyl terminus.
The E. coli strain YMC9 ( Ϫ thi-1 ⌬lacU169) (1) carrying pCB1603 was grown at 37°C in LB medium supplemented with ampicillin to a density of 25 Klett units, after which the temperature was raised to 42°C to induce the expression of ArgP-His, and incubation was continued to a density of 100 Klett units. The E. coli cells were harvested by centrifugation, washed, suspended at 100-fold concentration in cracking buffer (0.1 M sodium phosphate [pH 7.0], 0.5 M NaCl, 10 mM imidazole, 2.5 mM MgSO 4 , 10% [vol/vol] glycerol, 1 mM 2-mercaptoethanol) and subjected to sonic disruption on ice. The cellular debris was pelleted by centrifugation at 4°C, and the soluble fraction containing the bulk of the ArgPHis was purified by nickel-affinity chromatography (Amersham and Qiagen) as described previously for the His-tagged NAC protein (22) Fractions containing elevated levels of gdhAp-binding activity were stored at Ϫ20°C until used. The storage buffer used to dilute affinity-purified ArgP-His contains equal volumes of elution buffer and glycerol. Purified ArgP-His was more than 90% pure as determined by denaturing polyacrylamide gel electrophoresis (data not shown).
When mobility shift experiments were carried out using affinity-purified ArgPHis, storage buffer was used in place of sonication buffer, and dilutions of purified ArgP-His in storage buffer were used in place of extracts.
DNase I protection assay. The region of gdhAp bound by ArgP-His was determined by using the DNase I protection technique as described previously (8) . Essentially, 0.7 g (0.15 pmol) of end-labeled pCB725 DNA in 32 l of DNase I digestion buffer (140 mM KCl, 9.3 mM Tris HCl [pH 7.0], 4.7 mM MgCl 2 , 0.93 mM CaCl 2 , 47 g BSA/ml, 1.9 mM DTT, 4.0 g calf thymus DNA) with or without a 0.7 mM L-lysine HCl supplement was mixed with 8 l of either storage buffer or diluted samples of affinity-purified ArgP-His. After a 5-min incubation at room temperature, the DNA-protein solutions were mixed with 5 l of either DNase I dilution buffer or 0.56 mU/l DNase I (Roche) in DNase I dilution buffer and incubated for 60 s at 37°C. The end-labeled DNA was then precipitated with ethanol, pelleted by centrifugation, dissolved in loading solu- 
RESULTS
Disruption of the argP gene reduced the activity and the lysine-dependent regulation of gdhAp. The CB532 construct carries ⌽(gdhApЈ-ЈlacZ), in which the wild-type gdhA promoter is fused to the lacZ reporter gene. The activity of ⌽(gdhApЈ-ЈlacZ), hereafter referred to as gdhAp, was reduced threefold or more in response to either supplementation of the minimal medium with lysine to 550 M or disruption of the argP gene (Table 1 , KC5998 and KC6540). Although the lysine-dependent regulation of gdhAp was substantially reduced in the absence of a functional argP gene, a limited degree of lysinedependent regulation persisted in the argP28 KC6540 strain. Additionally, the argP-dependent regulation of gdhAp was essentially abolished in the presence of the lysine supplement. The interrelated natures of the lysine-dependent and the argPdependent regulations of gdhAp support the suggestion that ArgP is the lysine-sensitive transcriptional activator of gdhAp.
The ability of an argP-dependent factor to bind gdhAp is lysine sensitive. Electrophoretic mobility shift assays indicated that the extracts prepared from minimal medium-grown cultures of KC5998 contained an argP-dependent factor that bound the DNA target carrying gdhAp (Fig. 2, lanes 1, 2, and  5 ). The presence of 550 M lysine in the growth medium used to prepare the extracts did not strongly influence the quality or quantity of this DNA-binding factor (Fig. 2, lanes 4 and 5) . However, the presence of 55 M lysine in the DNA-binding solution strongly inhibited the ability of this factor to bind the DNA target (Fig. 2, lanes 5 to 8) . These results are consistent with the notion that exogenous lysine accumulates within the cell to levels that inhibit the binding of an argP-dependent transcriptional activator to gdhAp in vivo, effectively abolishing the argP-dependent regulation of gdhAp.
The presence of 50 M canavanine in the DNA-binding solution strongly inhibited the ability of this argP-dependent factor to bind gdhAp (data not shown). Although the presence of 100 M arginine in the DNA-binding solution did not influence the ability of this factor to bind gdhAp, the presence of 1 mM arginine strongly inhibited this interaction (data not shown). The presence of 1 mM 2-oxoglutarate, 1 mM L-glutamine, or 1 mM L-glutamate in the DNA-binding solution did not influence the ability of this factor to bind gdhAp (data not shown). The abilities of lysine, arginine, and canavanine to influence the binding of this argP-dependent factor to gdhAp further suggest that this factor is ArgP.
The lysine-sensitive binding of this factor to gdhAp in vitro is strongly reflected in the lysine-dependent regulation of gdhAp in vivo. In contrast, neither the 10 mM arginine nor the 500 M canavanine supplement reduced the activity of gdhAp by more than 30% in vivo (data not shown). The relative insensitivity of gdhAp to exogenous arginine and canavanine suggests that these supplements do not accumulate intracellularly to levels that substantially inhibit the binding of ArgP to gdhAp in vivo.
To further test the identity of this argP-dependent factor, a modified version of the ArgP polypeptide carrying a histidine affinity tag, ArgP-His, was overexpressed from plasmid pCB1603 12) . The extracts were prepared from cultures of either argP28 strain KC6540 (lane 2) or wild-type strain KC5998 (lanes 3 to 8), grown in minimal medium without (Ϫ) (lanes 2 and 5 to 8) or with (ϩ) (lanes 3 and 4) a 550 M L-lysine HCl supplement. Purified ArgP-His (1.8 pmol monomer/l) was diluted 81-fold (lane 12) or 243-fold (lanes 10 and 11), and 1-l portions were added to the DNA-binding solutions. For lanes 2 to 12, the DNA-binding solutions contained the indicated concentrations of L-lysine HCl. The samples were loaded onto a polyacrylamide gel, and the free and shifted DNA fragments were separated by electrophoresis. The positions of the end-labeled DNA were visualized by autoradiography of the dried gels. The labeled arrows at the left indicate the extent of migration of the free and bound DNA targets through the gel. a Cells were grown to mid-exponential phase in GNgln minimal medium containing glucose at 0.4% (wt/vol), ammonium sulfate at 0.2% (wt/vol), glutamine at 0.2% (wt/vol), and the indicated final concentrations of L-lysine HCl.
b ␤-Galactosidase-specific activities represent the averages of three or more independent determinations, with a standard error of measurement that is less than 10% of the average.
c Numbers in brackets represent the positions of the indicated substitutions relative to the gdhA transcription start sites. and purified by affinity chromatography. Electrophoretic mobility shift assays using purified ArgP-His indicated that such preparations contained high concentrations of an activity whose ability to bind gdhAp was lysine sensitive (Fig. 2, lanes 9  to 12) . When elevated levels of ArgP-His were used, an additional bound target band was seen that represents a loweraffinity interaction of ArgP with gdhAp (Fig. 2, lane 12) . Additional in vitro studies indicated that this additional interaction involves the region from approximately ϩ20 to ϩ70, relative to the gdhA transcription start site, and is of little physiological significance in vivo (data not shown).
DNase I footprint analysis of ArgP-His at gdhAp. The DNase I footprint analysis of gdhAp indicated that purified ArgP-His protected the region from approximately Ϫ100 to Ϫ50 from DNase I digestion and induced a region of DNase I hypersensitivity near position Ϫ74 (Fig. 3, lanes 2 to 5, and Fig. 4) . Additionally, the presence of 500 M lysine in the DNAbinding solution abolished these regions of protection and hypersensitivity (Fig. 3, lane 6 ). Within the promoter distal half of this footprint, a match to the LTTR consensus binding motif (5Ј-T-N 11 -A-3Ј) (24) can be found, centered at position Ϫ89 (Fig. 4) . This pattern of protection and hypersensitivity is typical of that reported for other LTTR proteins (24) and suggests that the regions from approximately Ϫ100 to Ϫ80 and from approximately Ϫ70 to Ϫ50 correspond to the RBS and ABS, respectively, for ArgP at gdhAp (Fig. 4) . The results of this DNase I footprint analysis provide strong support for the notion that ArgP is the argP-dependent factor whose ability to bind the upstream region of gdhAp is lysine sensitive. Thus, this factor will hereafter be referred to as ArgP.
Substitution analysis of the ArgP binding site. Mobility shift experiments indicated that ArgP bound a DNA target carrying the region of gdhAp from Ϫ100 to Ϫ51 and a target carrying the region of gdhAp from Ϫ100 to Ϫ60. In contrast, ArgP did not bind a target carrying the limited region of gdhAp from Ϫ116 to Ϫ71 (data not shown). These results suggest that the interaction of ArgP with its RBS does not firmly anchor ArgP to gdhAp and that the interaction of ArgP with its ABS is required for ArgP to bind gdhAp. To further define regions of The CB1064 construct carries ⌽(gdhAp A(Ϫ96)TЈ-ЈlacZ), in which the modified gdhA promoter carrying the A(Ϫ96)T substitution, just upstream of the LTTR consensus binding motif centered at Ϫ89, is fused to the lacZ reporter gene (Fig. 4) . When it was present in argP ϩ backgrounds, this substitution reduced gdhAp activity more than twofold and largely abolished the lysine-dependent regulation of gdhAp (8) . Although the A(Ϫ96)T substitution abolished the argP-dependent regulation of gdhAp, it did not significantly alter the argP-independent activity of gdhAp (Table 1 , KC6540, KC6881, and KC6882). The reduced binding of ArgP to the gdhAp target carrying the A(Ϫ96)T substitution in vitro (Fig. 5, lanes 2 and  4) is consistent with the argP-dependent defects resulting from this substitution in vivo. Thus, the base pair at Ϫ96 appears to provide an interaction that is necessary for ArgP binding in vivo.
The CB1938 construct carries ⌽(gdhAp T(Ϫ65)AЈ-ЈlacZ), in which the modified gdhA promoter carrying the T(Ϫ65)A substitution is fused to the lacZ reporter gene. The T(Ϫ65)A substitution lies within the ArgP ABS at gdhAp. This substitution essentially abolished the argP-dependent regulation of gdhAp and increased the argP-independent activity of gdhAp by more than 50% (Table 1 , KC6540, KC6923, and KC6924). The reduced binding of ArgP to the gdhAp target carrying the T(Ϫ65)A substitution in vitro (Fig. 5, lanes 6 and 10) is consistent with the argP-dependent defects resulting from this substitution in vivo. Thus, the base pair at Ϫ65 appears to provide an interaction with the ABS that is necessary for ArgP binding in vivo.
The CB1703 construct carries ⌽(gdhAp GTC(Ϫ54 to Ϫ52) TATЈ-ЈlacZ), in which the modified gdhA promoter carrying the GTC(Ϫ54 to Ϫ52)TAT substitution is fused to the lacZ reporter gene. The GTC(Ϫ54 to Ϫ52)TAT substitution together with the thymidine residue at position Ϫ65 of gdhAp generates the LTTR consensus binding motif centered at Ϫ59 within the ArgP ABS at gdhAp (Fig. 4) . The GTC(Ϫ54 to Ϫ52)TAT substitution did not strongly alter the argP-independent activity of gdhAp (Table 1 , KC6540 and KC6907). Nor did the substitution strongly alter the approximately fourfold lysine-dependent decrease in gdhAp activity in the argP ϩ background (Table 1, KC5998 and KC6410). However, this substitution did facilitate the argP-dependent regulation of gdhAp in cultures grown in the presence of exogenous lysine (Table 1, KC6410 and KC6907). Additionally, this substitution more than doubled the activities of gdhAp when they were determined in cultures of argP ϩ strains grown in both the absence and the presence of 550 M lysine (Table 1 , KC5998 and KC6410). The GTC(Ϫ54 to Ϫ52)TAT substitution did not strongly increase the binding of ArgP to gdhAp in vitro when lysine was not present in the DNA-binding solution (Fig. 5, lanes 6, 8, 11 , and 13). However, this substitution did substantially increase the binding of ArgP to gdhAp in vitro when the DNA-binding solution contained 55 M lysine (Fig. 5, lanes 12 and 14) . As the GTC(Ϫ54 to Ϫ52)TAT substitution appeared to reduce the influences of lysine on ArgP-gdhAp interactions in vivo and in vitro, these results are consistent with the notion that this substitution provides additional interactions that increase the binding of at least the lysine-bound conformation of ArgP to gdhAp in vivo.
DISCUSSION

Role of ArgP in the lysine-dependent regulation of gdhAp.
This report identifies ArgP, the product of the argP gene, as the lysine-sensitive factor postulated to bind the upstream region of gdhAp and stimulate promoter activity approximately threefold when K. pneumoniae is grown in minimal medium (8) . The parallels between the lysine-sensitive binding of ArgP to gdhAp in vitro and the lysine-dependent regulation of gdhAp in vivo suggest a mechanism where, during growth in minimal medium, exogenous lysine accumulates within the K. pneumoniae cytoplasm. At high intracellular concentrations, lysine binds to and causes ArgP to adopt a conformation that has a reduced affinity for its binding site at gdhAp. Such a lysinemediated reduction in affinity might effectively prevent ArgP from binding to its site at gdhAp. In the absence of binding to its site at gdhAp, ArgP is unable to interact productively with the transcriptional apparatus and stimulate transcription from gdhAp. Such a mechanism provides a simple yet effective mechanism by which exogenous lysine can limit GDH levels in enteric bacteria.
The lysine-sensitive binding of ArgP to gdhAp represents an interesting variation from the emerging paradigm by which many members of the LTTR family regulate their target promoters (see the introduction), in that ArgP does not appear to be firmly anchored to its RBS at gdhAp by the interactions that typically occur between the LTTR and the RBS. This inability of ArgP to anchor to the RBS at gdhAp makes the binding of ArgP to gdhAp dependent upon the strength of what are normally secondary interactions between the LTTR and the ABS. 6 and 11 to 12 ) or comparable pRJ800 derivatives carrying modified gdhA promoters (lanes 1 to 2, 7 to 10, and 13 to 14) were incubated with sonication buffer (lanes 1, 3, 5, 7, and 9) or KC5998 extract (lanes 2, 4, 6, and 8 and 10 to 14) prepared as described in Fig. 2 . For lanes 12 and 14, the DNA-binding solutions were supplemented with 55 M L-lysine HCl. After the extract was added to the DNA-binding solution, the samples were subjected to electrophoresis as described in the legend to Fig. 2 The data presented here suggest that the effector-free conformation of ArgP is able to interact with the ABS in a manner that compensates for the atypically weak ArgP-RBS interaction. In contrast, the lysine-bound conformation of ArgP appears to be unable to interact with the ABS in a similar manner. Thus, the ability of lysine to inhibit the binding of ArgP to gdhAp in vitro is consistent with an atypically low affinity of ArgP for its RBS and a substantial difference in the affinities of the effector-free and lysine-bound conformations of ArgP for the ABS.
Role of ArgP in the weak NAC-mediated repression of gdhAp. As ArgP appears to be the lysine-sensitive activator of gdhAp, ArgP must also be the target of the weak repression of gdhAp that occurs when NAC is expressed in minimal medium-grown K. pneumoniae (8) . The features of this weak NAC-mediated repression suggest that it is facilitated by the mutually exclusive binding of NAC and ArgP to the upstream region of gdhAp (8, 22) . The binding site of ArgP at gdhAp, which spans the region from Ϫ100 to Ϫ50 of gdhAp, overlaps the upstream binding site of NAC at gdhAp, which spans the region from Ϫ100 to Ϫ75 of gdhAp (8) . The overlapping nature of the ArgP and NAC binding sites, as well as the abilities of the A(Ϫ96)T substitution to reduce the binding of NAC (8) and the binding of ArgP to gdhAp in vitro, is consistent with the notion that the binding of NAC and ArgP to the upstream region of gdhAp might be mutually exclusive. Thus, NAC and lysine may directly prevent ArgP from binding to its site at gdhAp in vivo.
The atypically weak ArgP-RBS interaction at gdhAp conceivably limits the stability of the ArgP-gdhAp complex in vivo, even during culturing in minimal medium lacking lysine. The limited stability of this complex might increase the frequencies at which ArgP disassociates from its site at gdhAp, and NAC can bind to its site centered at Ϫ89. Thus, the atypically weak interaction of ArgP with its RBS at gdhAp might facilitate the ability of NAC and of lysine to directly prevent the binding of ArgP to its site at gdhAp in vivo.
Roles of binding site sequences in the binding of ArgP to DNA. Although several reports have described the binding of ArgP, also designated IciA, to DNA (11) , only the report of the binding of ArgP to argOp in E. coli describes the influences of low-molecular-weight effectors on this interaction in vitro (11) . Only a few aspects of the binding of ArgP to argOp in E. coli are also seen in the binding of ArgP to gdhAp in K. pneumoniae. Of these aspects, it should be noted that the effectorfree conformation of ArgP binds both target promoters in vitro. Of the many differences, perhaps the one aspect that most strongly distinguishes these two ArgP-DNA binding interactions is that lysine increases the affinity of ArgP for its binding site at argOp in E. coli more than threefold (11) . This difference suggests that ArgP interacts with its binding sites at these promoters in substantially different manners. The contribution of the 4% divergence of the amino acid sequences of the K. pneumoniae and the E. coli ArgP polypeptides to this difference has not yet been assessed. However, differences between the DNA sequences of the ArgP binding sites may strongly contribute to the different interactions between the ArgP proteins and their binding sites at these promoters.
The E. coli ArgP protein binds the region from approximately Ϫ85 to Ϫ20, relative to the E. coli argO transcription start site (11) . The DNA sequences of the ArgP binding sites at the E. coli argO and the K. pneumoniae gdhA promoters share a common promoter distal sequence, 5Ј-AT-N 3 -TTTT-N 4 -AT-3Ј, centered at positions Ϫ63 and Ϫ89, respectively (Fig. 4) . This common promoter distal sequence is centrally located within the regions corresponding to the ArgP RBS of these promoters and contains the LTTR consensus binding motif that, though often necessary, is itself insufficient for LTTR binding (Fig. 4) . Additionally, the first deoxy-adenosine residue of this common RBS-associated sequence corresponds to that at position Ϫ96 of the K. pneumoniae gdhA promoter (Fig.  4) , which is required for the interaction of ArgP with the K. pneumoniae gdhA promoter in vivo and in vitro. This common RBS-associated sequence may provide interactions that are required for the binding of ArgP to these promoters.
The activity of the E. coli gdhA promoter is stimulated in an argP-dependent, lysine-sensitive manner in vivo (T. Goss, manuscript in preparation). In addition, the E. coli gdhA promoter is bound by an argP-dependent factor whose ability to bind the promoter region is lysine sensitive (T. Goss, manuscript in preparation). The RBS-associated sequence that is common to both the K. pneumoniae gdhA and the E. coli argO promoters is also found in the upstream region of the E. coli gdhA promoter (http://www.ncbi.nlm.nih.gov/GenBank/index .html) (Fig. 4) . Although the DNA sequence of the region from Ϫ100 to Ϫ80 of the K. pneumoniae gdhA promoter is more than 80% identical to the comparable region of the E. coli gdhA promoter, these regions are less than 50% identical to the comparable region of the E. coli argO promoter (Fig. 4) . Despite the presence of the common RBS-associated sequence, the divergence of this region of argOp from the comparable regions of the two gdhA promoters suggests that the DNA sequence of the ArgP RBS may contribute to the different abilities of these regions to strongly anchor ArgP to the argO and gdhA promoters in vivo during growth in the presence of exogenous lysine.
When a single nucleotide gap is introduced in the sequence of the E. coli argO promoter to maximize its homology to the sequences of the two gdhA promoters, all three promoters contain the common promoter proximal sequence 5Ј-TTATN AATTT-3Ј (Fig. 4) . This common promoter proximal sequence is asymmetrically positioned within the regions corresponding to the ArgP ABS of the K. pneumoniae gdhA and E. coli argO promoters (Fig. 4) . The third thymidine residue of this common ABS-associated sequence corresponds to that at position Ϫ65 of the K. pneumoniae gdhA promoter (Fig. 4) that is required for the interaction of ArgP with the K. pneumoniae gdhA promoter in vivo and in vitro. This common ABS-associated sequence may be important for the ArgP-DNA interactions that are common to the gdhA and argO promoters, suggesting that this sequence facilitates binding of ArgP to all three of these promoters in vivo, during growth in the absence of exogenous lysine.
The DNA sequences of all three promoters diverge substantially in the regions comparable to the span from Ϫ58 to Ϫ50 of the K. pneumoniae gdhAp promoter (Fig. 4) . Within these divergent regions, neither gdhAp contains deoxy-adenosine residues at positions comparable to that at position Ϫ28 of argOp. Thus, neither gdhAp contains LTTR consensus binding motifs at positions comparable to that centered at Ϫ34 at VOL. 190, 2008 ArgP STIMULATES gdhAp 4357
on February 21, 2013 by PENN STATE UNIV http://jb.asm.org/ argOp (Fig. 4) . The GTC(Ϫ54 to Ϫ52)TAT substitution at the K. pneumoniae gdhA promoter introduces a deoxy-adenosine residue at a position comparable to that at position Ϫ28 of argOp and generates the LTTR consensus binding motif at a position comparable to that centered at Ϫ34 at argOp (Fig. 4) . Thus, the GTC(Ϫ54 to Ϫ52)TAT substitution improves the homology of the region from Ϫ58 to Ϫ50 of the K. pneumoniae gdhA promoter to the comparable region of argOp. The GTC(Ϫ54 to Ϫ52)TAT substitution also improves the interaction of ArgP with gdhAp in the presence of lysine, in vivo and in vitro. The extent of DNA sequence homology between these regions of the E. coli argO and the K. pneumoniae gdhA promoters parallels the abilities of these promoters to interact with ArgP in the presence of lysine. This parallel suggests that the DNA sequence of the promoter proximal half of the ArgP ABS at the gdhA and argO promoters contributes to the different affinities of ArgP for these promoters in vivo, during growth in the presence of exogenous lysine. Finally, it should be noted that although the effector-free conformations of ArgP bind gdhAp and argOp in vitro, this conformation of ArgP appears to stimulate gdhAp, yet fails to stimulate argOp (11) . As the ArgP binding site at gdhAp is approximately 30 bp farther upstream from the transcription start site than that at argOp, this architectural difference may influence the ability of effector-free ArgP to stimulate transcription in vivo.
Role of lysine in the regulation of gdhAp. The lysine-dependent regulation of gdhAp influences the cell's capacity to make glutamate, which serves roles as counterion to K ϩ in osmotic pressure homeostasis (reviewed in reference 6) and primary amino group donor in the biosynthesis of approximately 80% of all nitrogenous compounds in the cell (reviewed in reference 21). As the intracellular levels of glutamate required for osmotic homeostasis might differ from those required for biosynthesis under various growth conditions, the extent to which glutamate fulfills these two roles may be independently monitored by means that do not reflect glutamate levels per se. The extent to which glutamate fulfills its requirement for the biosynthesis of other nitrogenous compounds might be signaled by the intracellular levels of one or more key nitrogenous compounds. Of the 20 common amino acids, lysine is noteworthy in that, despite its relatively high nitrogen content, enteric bacteria do not readily use lysine as a source of nitrogen or even carbon (4, 9, 28) . Despite its lack of utility as a growth substrate, lysine can be decarboxylated to cadaverine, which is either used as a polyamine (5) or excreted as a means of neutralizing an acidic environment (27) . Additionally, the size of the intracellular pool of lysine is likely to be related to that of its immediate precursor, diaminopimelate, which is required for cell wall biosynthesis (19) . These unique roles and features of lysine could account for its possible use as one such key nitrogenous compound that may serve as a surrogate for glutamate in signaling the extent of glutamate overflow from osmotic pressure homeostasis into the biosynthetic pathways for other nitrogenous compounds. In such a capacity, lysine levels may be one of several signals that mediate the feedback regulation of gdhAp, allowing enteric bacteria to fine tune their glutamate biosynthetic capacities to achieve both osmotic and biosynthetic homeostasis.
NAC and ArgP are the only factors currently known to directly bind and regulate gdhAp in enteric bacteria. The regulation of gdhAp by NAC and ArgP provides a rare example of the physiologically relevant, opposing regulation of a promoter by two dissimilar LTTR family members.
